The A-share innovative drug sector weakened in early trading, with Tianjin Pharmaceutical Group hitting the daily limit down, BeiGene falling nearly 4%, and Hengrui Medicine, WuXi AppTec, and others following suit.
2026-05-18
The A-share innovative drug sector weakened in early trading, with Tianjin Pharmaceutical Group hitting the daily limit down, BeiGene falling nearly 4%, and Hengrui Medicine, WuXi AppTec, and others following suit.